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Objectives: Early detection of Mycobacterial tuberculosis
infection (MTB) is pivotal for the treatment of tubercu-
losis (TB).
Background: This study was performed to evaluate the
performance of BD ProbeTec ET direct detection assay
(DTB) against the gold standard culture technique for
confirmation of MTB infection.
Patients and methods: A total of 266 consecutive and
non-duplicate clinical specimens for detection of MTB
were included in this study. There were 118 respiratory
and 148 non-respiratory samples. All samples were tested
by microscopy for acid-fast bacillus (AFB), MTB culture
and biochemical identification with simultaneous testing
by DTB.
Results: A total of 88 samples (33%) were culture-
positive for MTB including 39/118 respiratory, 29/99
fluid and 20/49 tissue samples. DTB sensitivity forCorresponding address: Department of Pathology/Microbi-
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umed.2016.09.005respiratory samples was 97% and specificity was 96%
with a positive predictive value (PPV) of 93% and
negative predictive value (NPV) of 99%. Sensitivity of
DTB in fluid samples was 80%, specificity 88%, PPV
69% and NPV 93% whereas sensitivity of DTB for tissue
samples was 25%, specificity 90%, PPV 63% and NPV
63%. Of the 50 (56.8%) smear-positive samples, DTB
sensitivity was 100% for respiratory, 85% for fluid and
100% for tissue samples.
Conclusion: DTB performed within acceptable limits for
the rapid detection of MTB in respiratory samples
compared to fluid and tissue specimens.
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Infections with Mycobacterium tuberculosis (MTB) is
conventionally diagnosed by smear and/or culture tech-
niques. While the culture technique is still considered to be
the gold standard, it yields results after weeks of delay and
diagnosis by the smear technique lacks sensitivity that mayhis is an open access article under the CC BY-NC-ND license
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A.M. Somily et al.2range from 50 to 80%.1 Early detection of infection with
MTB is of paramount importance for the immediate
isolation and treatment of infected patients and their
contacts. This may be possible by direct detection of
tubercle bacilli in clinical samples by the application of
different laboratory procedures such as amplification of
mycobacterial DNA,2 detection of specific lipids3 and
serological evidence for cell surface proteins.4 Despite the
availability of these methods, microscopy for acid-fast
bacilli (AFB) remains the most cost effective and is a rela-
tively simple method for direct detection of MTB in clinical
specimens.5
Reliance on detection of MTB by microscopy is further
complicated by the occurrence of mycobacteria species other
than tubercle bacilli that may be responsible for 30% ormore
of mycobacterial infections.6 Although these organisms are
non-contagious, they may yield a positive acid-fast bacillus
smear. It is therefore imperative that accurate diagnosis of
MTB and M. tuberculosis complex (MTBC) be sought
because of the infectious nature of the organism. It was for
this reason that a number of techniques based on polymerase
chain reaction (PCR) amplification of Mycobacterium spe-
cific nucleic acids were introduced7e10 for the direct detection
of MTB; this includes the BD ProbeTec ET MBTC direct
detection assay (DTB).11 The DTB assay is a semi-
automated real-time molecular technique that targets MTB
specific DNA (IS6110) using specific primers and fluo-
rescently tagged probes. Evaluation of the diagnostic efficacy
of the DTB assay in pulmonary samples such as bron-
choalveolar lavage and sputum has clearly documented
better performance of the DTB assay compared to smear
microscopy.12 This study was performed to assess the
performance of DTB with regards to detection of MTBC
in respiratory and non-respiratory clinical samples from
patients suffering from tuberculosis at King Khalid Uni-
versity Hospital.Materials and Methods
This was a prospective study of 266 consecutive and
non-duplicate clinical specimens received in the laboratory
at King Khalid University Hospital between June 2009 and
December 2011 for detection of MTB. Among these sam-
ples, there were 118 respiratory and 148 non-respiratory
specimens, comprising 99 samples from sterile body fluid
sites and 49 samples from various tissues. All samples from
non-sterile body sites were decontaminated with N-acetyl-
L-cysteineeNaOH (2% final concentration) and concen-
trated by centrifugation by the same technical staff. Sam-
ples from sterile sites were homogenized when required
prior to re-suspension in normal saline and concentrated
by centrifugation. All of the specimens were processed in
accordance with the laboratory policy for AFB smear
microscopy and MTB culture using both solid (Low-
enstein-Jensen) medium and liquid Mycobacteria Growth
Indicator Tube (MGIT; BD Biosciences, Sparks MD)
medium. Identification of MTBC was finally performed by
biochemical testing. All the samples were simultaneously
tested by DTB. After the completion of all procedures,
results from microscopy, culture and DTB were collated
and evaluated.Please cite this article in press as: Somily AM, et al., Performance of the BD
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Initial processing of the samples was performed in a class 2
biological safety cabinet within a category 3 containment
laboratory. The BD ProbeTec ET Direct TB Assay was
performed in accordance with themanufacturers’ instructions
as described previously.13 Briefly, a 500 ml aliquot of
decontaminated sample was added to 1 ml of wash buffer
and the contents were mixed by vortexing, which was
followed by centrifugation in a microfuge. Cells in the pellet
were rendered non-viable by heating in a self-contained
oven. Following that, the pellet was resuspended in 100 ml
of lysis buffer. The contents were mixed and placed in a sonic
water bath for 45 min, followed by another round of centri-
fugation. The pellet was resuspended again in 600 ml of
sample neutralization buffer and the mixture vortexed,
centrifuged and analysed. Positive and negative controls
supplied by the manufacturers were also prepared simulta-
neously. An eight channel ProbeTec pipette was used to
dispense 150 ml of each sample into a microwell of the priming
plate and incubated for 20 min at room temperature. After
the incubation, the priming plate was placed on a heating
block at 53.5 C for 10 min for pre-warming, followed by the
transfer of 100 ml of sample from each priming microwell to
an amplification microwell. The wells were sealed and placed
into the BD ProbeTec ET instrument for 60 min. After one
hour, Metric Other Than Acceleration (MOTA) values were
printed by the instrument for each sample and control.
MOTA values higher than 3400 were considered positive for
MTBC DNA. The result was considered negative if the MTB
MOTA value was less than 3400 and the Internal Amplifi-
cation Control (IAC) was more than 5000. The results with
MTBMOTA values of less than 3400, and IAC less than 5000
were interpreted as sample inhibition. The duration of the
DTB assay for confirmation of TB diagnosis was between
three to four hours that was markedly shorter than the culture
method that usually takes six to eight weeks.Results
Of the 266 total clinical samples tested, 88 (33%) yielded
evidence of the presence of MTB by the culture technique.
Table 1 describes data for the ability of the DTB assay to
detect MTBC among samples from respiratory and non-
respiratory sites, which tested either positive or negative by
the culture technique which is considered the gold standard.
Of the total of 118 respiratory samples, MBTwas found in 39
samples by culture, whereas the remaining 79 samples yiel-
ded no evidence of MTB. DTB detected MTBC in 38 out of
39 culture-positive specimens whereas 3 of 79 culture-
negative samples were tested positive by DTB. Of the 99
fluid samples from sterile body sites 29 samples were culture-
positive whereas 70 samples tested negative by the culture
technique. Of the 29 culture-positive fluid samples, the DTB
was able to detect MTBC in only 20 samples, whereas in 70
culture-negative samples, 5 samples yielded a positive result
when tested by the DTB. For the tissue samples, of the 49
total samples, only 20 grew MTB, and of these 20 samples,
the DTB was able to detect MTBC in only 5 samples. Of the
remaining 29 samples tested negatively by culture, the DTB
could detect MTBC in 3 samples.ProbeTec ET direct detection assay for the analysis of Mycobacterium
f Taibah University Medical Sciences (2016), http://dx.doi.org/10.1016/
Table 1: Mycobacterium tuberculosis detection by DTB and
culture technique.
Specimen type Culture Total
Positive Negative
Respiratory DTB Negative 1 76 77
Positive 38 3 41
Total 39 79 118
Fluid DTB Negative 9 65 74
Positive 20 5 25
Total 29 70 99
Tissue DTB Negative 15 26 41
Positive 5 3 8
Total 20 29 49
All samples DTB Negative 25 167 192
Positive 63 11 74
Total 88 178 266
Detection of M. tuberculosis 3Figure 1 shows data for DTB performance against the
gold standard culture technique for detection of MTB.
Among the three types of samples tested, the efficiency of
DTB in detection of MTBC was remarkably high in
respiratory samples where its sensitivity was 97% and
specificity was 96%, with a positive predictive value of
93% and a negative predictive value of 99%. DTB
performance in detection of MTBC in fluid samples was
found to be better than its ability to detect MTBC in tissue
samples. This was evident by a sensitivity of 80% and
specificity of 88%, with a positive predictive value of 69%
and a negative predictive value of 93% in fluid samplesFigure 1: Performance of the BD ProbeTec ET Direct TB (DTB) assa
Mycobacterium tuberculosis in respiratory and non-respiratory sample
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25% and specificity was 90%, with a positive predictive
value of 63% and negative predictive value of 63%.
Of the 88 total culture-positive clinical samples, AFB in
smear microscopy was detected in 50 (56.8%). Among 118
respiratory samples, 33 (28%) were AFB smear-positive, and
of the 99 fluid samples 15 (15%) were smear-positive,
whereas in 49 tissue samples only 2 (4%) samples yielded
direct evidence of the presence of AFB by microscopy.
Figure 2 describes data for DTB sensitivity among smear-
positive and smear-negative samples in all categories.
Sensitivity of the DTB among the smear-positive respiratory
samples was 100%, whereas in smear-negative respiratory
samples, the sample had a sensitivity of 86%. Among the
fluid samples, the sensitivities of smear-positive and smear-
negative samples were 85.7% and 53%, respectively,
whereas in smear-positive and smear-negative tissue samples,
these were 100% and 16.6%.Discussion
Performance of DTB for rapid detection of MTBC
against the gold-standard culture technique in clinical res-
piratory samples was better in comparison to non-
respiratory samples. To provide rapid and accurate results
it is necessary for a diagnostic test should have high sensi-
tivity and specificity. The sensitivity (97%), specificity (96%),
positive predictive value (93%) and negative predictive value
(99%) of DTB in the detection of MTBC in the present study
of respiratory samples was better than the previouslyy against the gold standard culture technique for the detection of
s.
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Figure 2: Sensitivity of the BD ProbeTec ET Direct TB (DTB) assay among acid-fast bacillus smear-positive and smear-negative sample in
all categories.
A.M. Somily et al.4reported sensitivity, specificity, positive predictive value and
negative predictive values of 89.7%, 93.7%, 85.4%, and
95.7%, respectively. Sensitivity of DTB as low as 63.2% has
also been reported14 which appears to be lower than a
number of other studies reporting sensitivity of the DTB
ranging from 82.7% to 100% for the detection of MTBC
in respiratory specimens.15,16 The findings of this study are
consistent with previous reports of DTB being a highly
sensitive and specific test with a higher negative predictive
value of 99.5%,17 making it a powerful tool for diagnosis
or exclusion of tuberculosis in respiratory specimens.
Despite its excellent performance in respiratory samples,
the performance of the DTB in extra-pulmonary specimens,
particularly in tissue samples from extra-pulmonary sites was
not comparable. The sensitivity and specificity of DTB in
detecting MTBC in tissue samples in this study was 25% and
90%, respectively. Similar results were also observed by
application of DTB in a study examining formalin fixed
paraffin embedded tissue samples with necrotizing granulo-
matous inflammation, where the sensitivity and specificity of
DTB was 40% and 100%, respectively.18 The low sensitivity
in tissue samples may possibly be due to several purification
and preparation steps involved in the preparation of the
tissue samples before evaluation. Moreover, clinical
samples, particularly respiratory samples, are known to
harbour interfering substances responsible for false
negative results in detection of mycobacterial DNA19 that
may contribute to decreased sensitivity of PCR based
detection of MTB. On the contrary, the sensitivity of DTB
in smear-positive respiratory samples including tissue sam-
ples was 100% in this study where the DTB detected MTBC
in 28 of 33 samples. In agreement with findings from the
present study, of 20 tissue specimens from patients with a
confirmed diagnosis of tuberculosis, the DTB has been
shown to detect MTBC in 18 clinical samples with 100%Please cite this article in press as: Somily AM, et al., Performance of the BD
tuberculosis in respiratory and non-respiratory clinical specimens, Journal o
j.jtumed.2016.09.005specificity.18 Similarly, DTB has been reported to exhibit an
overall sensitivity, specificity, positive predictive value and
negative predictive value of 85%, 100%, 100% and 99%,
respectively for the detection of MTB in both respiratory
and non-respiratory samples.20 Despite the technical
hazards and low sensitivity in tissue samples observed in
the present study, DTB appears to be a highly sensitive
and specific assay that is capable of detecting MTB
accurately in clinical samples within three to four hours.
The low sensitivity of DTB in tissue samples could possibly
be due to a lack of standardization of the extraction
procedure for DNA from tissues.
Of the total of 178 culture-negative clinical specimens, 11
(6.1%) samples yielded positive results by DTB in this study.
DTB related false-positive results reported in the past were
frequently obtained in patients either receiving treatment for
pulmonary tuberculosis, old pulmonary tuberculosis patients
or due to the presence of M. abscessus in the clinical sam-
ples.21 It is possible that the detection of dead mycobacteria in
specimens detected by DTB may have yielded false positive
results. Since the present study was conducted utilizing
clinical specimens received in the microbiology laboratory
and lacked clinical details, it was difficult to ascertain the
current status of therapeutic intervention. In addition,
lower positive predictive value of DTB particularly among
non-respiratory specimens could be due to a higher number
of false positive results. Similarly, 25 of the 88 total culture-
positive specimens in the present study yielded false nega-
tive results particularly among the tissue samples where DTB
failed to detect MTBC in 15 out of 20 culture-positive sam-
ples. In addition to the presence of interfering substances in
the clinical samples,19 the most likely factors contributing to
false negative results may include the presence of small
numbers of mycobacteria, suboptimal target extraction or
unequal distribution of test material.ProbeTec ET direct detection assay for the analysis of Mycobacterium
f Taibah University Medical Sciences (2016), http://dx.doi.org/10.1016/
Detection of M. tuberculosis 5In conclusion DTB assay performance was comparable
with the gold standard culture method for early detection of
MTB in clinical samples. This study was however limited by
relatively small numbers conducted at a single centre. Large-
scale studies are recommended in the Kingdom to validate
the findings of the present study. Moreover, being that a mo-
lecular assayusesDTB, thismay prove tonot be a cost effective
approach in early case detection in a community setting.
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